avalw
⚲
The Quiet Nudge: How a New Tool Changes End of Life Care HEALTH · US

The Quiet Nudge: How a New Tool Changes End of Life Care

Fawn Mitchell Fawn Mitchell fawnmitchell.avalw.com · 69 reads Respect0 Save Share Read only
READS19live count PUBLISHED1 Nov2026 READING TIME4 min749 words LANGUAGEEnglish
AI CITATIONS? Gathering data

A new clinical tool from UNC Lineberger aims to help oncologists recognize the right moment for difficult conversations about end of life care, using routine medical data to flag high risk without relying on artificial intelligence.

ALSO ON THE CREATOR SITERead this on fawnmitchell.avalw.comOpen

For Deborah Miller, a 72 year old resident of Pittsboro, the hardest part of her cancer journey is not the treatment itself but the silence that often follows diagnosis. Living with metastatic breast cancer since 2023, she finds that honest conversations about the future are the most important part of her care. Yet she admits it is hard to never be able to ring the bell, a metaphor for the uncertainty that hangs over every appointment. Her experience highlights a gap in oncology care that researchers at the University of North Carolina are trying to close with a new decision support tool.

The tool is designed to help oncologists recognize when patients with metastatic breast cancer may need discussions about end of life planning and supportive care. It does not rely on artificial intelligence, a deliberate choice by the development team to ensure transparency. Instead, it uses routine information already in a patient’s medical record to estimate risk. This approach aims to give doctors a clear, understandable nudge to start difficult conversations sooner, rather than waiting for a crisis to force the issue.

Reading the Data, Not Guessing

Emily Ray, a medical oncologist at UNC Lineberger and associate professor in the UNC School of Medicine, helped develop the tool. She explained that doctors often struggle to tell patients that their time may be limited. The emotional weight of these conversations is heavy, and the lack of a clear signal can lead to hesitation. The new tool provides that signal by analyzing existing data points such as lab results, vital signs, cancer subtype, and current medications.

The system estimates a patient's risk of death within 30 or 90 days. When that risk is high, the oncologist receives a simple notification flagging the patient. This is not a prediction of fate, but a clinical cue to reassess the care plan. Ray emphasized that the team intentionally avoided using artificial intelligence so that doctors could better understand how the tool reaches its conclusions. In a field where trust is paramount, explainability is a feature, not a bug.

Routine data points like lab results and vital signs are the foundation of the new tool.
Routine data points like lab results and vital signs are the foundation of the new tool.

The Case for Early Palliative Care

The ultimate goal of the tool is not just to have a hard conversation, but to lead to earlier use of palliative care. Palliative care focuses on comfort and support for people with serious illnesses. It is often misunderstood as being only for the very end of life, but Ray clarified that it can be provided alongside cancer treatment. In fact, it has been shown to improve quality of life by managing symptoms and supporting emotional well being.

By flagging patients who are at higher risk, the tool aims to bridge the gap between aggressive treatment and comfort care. This allows for a smoother transition where the patient’s goals are central. For someone like Miller, who values being listened to by her care team, this means getting the support she needs earlier, rather than in a rush at the very end. The tool supports this by making the need for such support visible and actionable for the clinician.

Palliative care focuses on comfort and support, allowing patients to live with dignity.
Palliative care focuses on comfort and support, allowing patients to live with dignity.

A Scale Problem

The need for better end of life planning is not a niche issue. According to the National Cancer Institute, more than 150,000 women in the United States are living with metastatic breast cancer. Each of these patients and their families faces the challenge of navigating a complex medical landscape. The lack of curative options for metastatic disease makes these conversations even more critical, as the focus shifts from cure to control and comfort.

The new tool is a response to this scale. It provides a standardized way to identify when these conversations are most needed, reducing the variability in clinical practice. This consistency can lead to better outcomes and less distress for patients and families. It is a practical solution to a human problem, grounded in data but driven by compassion.

The tool aims to facilitate honest, compassionate conversations between doctors and patients.
The tool aims to facilitate honest, compassionate conversations between doctors and patients.

What Comes Next

The study detailing this tool was published in JCO Oncology Practice in September. This publication marks a significant step in the validation of the approach. It provides evidence that such a tool can be effective and useful in a clinical setting. The research team is now moving from study to practice.

UNC plans to pilot the tool in its clinics next. This phase will test whether the tool works in real time and whether oncologists find it useful in their daily workflow. The feedback from this pilot will be crucial in refining the tool and potentially expanding its use to other cancer types or settings. For now, it represents a promising new chapter in how we approach end of life care.

Frequently asked questions

What specific data points does the new UNC tool use to estimate patient risk?

The tool analyzes routine information already present in a patient’s medical record, including lab results, vital signs, cancer subtype, and current medications. It uses these existing data points to estimate the risk of death within 30 or 90 days without relying on artificial intelligence.

Why did the development team decide to avoid artificial intelligence in this decision support tool?

The team intentionally excluded artificial intelligence to ensure transparency and explainability for clinicians. This design choice allows doctors to better understand how the tool reaches its conclusions, which is critical for maintaining trust in a field where clinical judgment is paramount.

How does the tool signal to oncologists that a patient needs end of life planning discussions?

When the system estimates a high risk of death within 30 or 90 days, it sends a simple notification flagging the patient to the oncologist. This serves as a clinical cue to reassess the care plan and initiate supportive care conversations earlier rather than waiting for a crisis.

Who is leading the development of this metastatic breast cancer decision support tool?

Emily Ray, a medical oncologist at UNC Lineberger and associate professor in the UNC School of Medicine, helped develop the tool. She works with a research team at the University of North Carolina that aims to close gaps in oncology care by making end of life planning more accessible.

What is the primary clinical goal of using this risk estimation tool in practice?

The main objective is to facilitate earlier use of palliative care alongside cancer treatment. By identifying patients at higher risk sooner, the tool helps bridge the gap between aggressive treatment and comfort care, improving quality of life and supporting emotional well being.

When was the study detailing this new tool published and what is the next step for its implementation?

The study was published in JCO Oncology Practice in September. Following this validation, UNC plans to pilot the tool in its clinics to test its effectiveness in real time and gather feedback from oncologists for potential expansion to other cancer types.

0 responses
No responses yet. Be the first to add one.
Fawn Mitchell
Follow this desk
Fawn Mitchell
Create a free account to follow Fawn Mitchell. New stories land in your feed, and you can save any of them to your own reading lists.
Your library & lists →
Fawn Mitchell
WRITTEN BY THE AUTHOR
Fawn Mitchell 2026-11-01 · 4 min read · 19 reads
View profile →
VERIFY THIS STORY
ASK AI
Fawn Mitchell Keep subscribing to Fawn MitchellHer next filing reaches you the moment it publishes, on her own subdomain.
Up next
More
Statistics Search Become a creator Alliances About Terms Privacy